Related by context. Frequent words. (Click for all words.) 74 multicenter clinical 72 randomized controlled clinical 71 prospective randomized controlled 71 placebo controlled clinical 69 multicentre 69 Multicenter 68 randomized Phase III 67 Phase Ib clinical 67 multicenter randomized 67 randomized clinical 66 Phase III randomized 66 prospective observational 66 multicenter study 66 phase IIa 65 retrospective cohort study 65 prospective randomized 64 PRECISE 64 SPIRIT III 64 multicenter 64 EORTC 63 blind randomized controlled 63 carotid artery stenting 63 Acute Myocardial Infarction 63 randomized controlled 63 multicenter randomized double 63 Phase 1b clinical 62 substudy 62 placebo controlled randomized 62 randomized controlled clinical trials 62 double blinded placebo 62 Thrombolysis 62 NSABP 62 label multicenter 62 blinded placebo controlled 62 Gynecologic Oncology Group 61 Pivotal Trial 61 ATTRACT 61 SWOG 61 PREVAIL 60 Carotid 60 randomized placebo controlled 60 active comparator 60 pharmacodynamic effects 60 subgroup analyzes 60 RTOG 60 randomized controlled trial 59 dabigatran etexilate 59 Phase 1b trial 59 Phase III Clinical Trial 59 Apixaban 59 SYNTAX 59 Phase Ia 59 confirmatory Phase III 59 phase IIb 59 pertuzumab 58 PRECiSE 58 Rosuvastatin 58 Phase Ib 58 TRITON TIMI 58 Randomized 58 Phase IIa trial 58 PFO closure 58 neoadjuvant 58 blind randomized 58 Phase 2a clinical 58 bronchial thermoplasty 58 Phase IIa clinical 57 SABCS 57 Phase 2b study 57 dose escalation trial 57 Stenting 57 Phase 2b clinical 57 placebo controlled 57 Amrubicin 57 Azedra 57 RESOLUTE 57 Pivotal Phase III 57 carotid stenting 57 placebo controlled studies 57 Phase III pivotal 57 superficial bladder cancer 57 ENDEAVOR 57 RADIANT 57 placebo controlled trials 56 National Surgical Adjuvant 56 ataluren 56 Phase 2a trial 56 ALLHAT 56 Phase IIb clinical 56 axitinib 56 Phase III clinical 56 tanespimycin 56 noninferiority 56 immunohistochemical 56 tesmilifene 56 rosuvastatin 56 unblinding 56 UPLIFT 56 registrational trial 56 secondary efficacy endpoints 56 Neuradiab